Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
After publication of the Original research article [1] it was brought to our attention that the sentence at the bottom of the section entitled Discussion (pag 6 of 9, just below Fig. 4) must be corrected as follows:
Main Authors: | Roberto W. Dal Negro, Paola Turco, Massimiliano Povero |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-11-01
|
Series: | Multidisciplinary Respiratory Medicine |
Online Access: | http://link.springer.com/article/10.1186/s40248-019-0204-5 |
Similar Items
-
Patients’ usability of seven most used dry-powder inhalers in COPD
by: Roberto W. Dal Negro, et al.
Published: (2019-09-01) -
Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD
by: Alfredo Chetta, et al.
Published: (2021-02-01) -
Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey
by: Massimiliano Povero, et al.
Published: (2014-06-01) -
Use of dry powder inhalers in acute exacerbations of asthma and COPD
by: Olof Selroos, et al.
Published: (2009-04-01) -
In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy
by: Ciciliani A, et al.
Published: (2017-05-01)